文献速递心境障碍焦虑、强迫与应激相关障碍儿童青少年精神

美国成人DSM-5进食障碍患病率及相关因素

Prevalence and Correlates of DSM-5-Defined Eating Disorders in a Nationally Representative Sample of U.S. Adults.
PubMed 文献 · Biol Psychiatry · 2018-04-17

基于2012-2013年美国全国酒精及相关状况流行病学调查的36,306名成人结构化访谈数据,报告DSM-5定义神经性厌食、神经性贪食和暴食障碍的终生与12个月患病率,并分析性别和种族差异及临床特征。

要点

  • 终生患病率:神经性厌食0.80%、神经性贪食0.28%、暴食障碍0.85%。
  • 12个月患病率:神经性厌食0.05%、神经性贪食0.14%、暴食障碍0.44%。
  • 调整年龄、种族/民族、教育和收入后,三种进食障碍终生和12个月诊断的 odds 女性均显著高于男性。

核心结论

  • DSM-5定义的神经性厌食、神经性贪食和暴食障碍在美国成人中终生患病率分别为0.80%、0.28%和0.85%,12个月患病率分别为0.05%、0.14%和0.44%。
  • 三种进食障碍的终生和12个月诊断 odds 女性均显著高于男性。
  • 神经性厌食终生诊断 adjusted odds ratio 在非西班牙裔黑人和西班牙裔受访者中显著低于白人受访者。

研究设计与样本

  • 研究为基于2012-2013年美国全国酒精及相关状况流行病学调查的全国代表性样本。
  • 样本包括36,306名美国成人,完成结构化诊断访谈(酒精使用障碍及相关残疾访谈量表-5)。

主要发现

  • 终生神经性厌食、神经性贪食和暴食障碍患病率分别为0.80%(SE 0.07%)、0.28%(SE 0.03%)和0.85%(SE 0.05%)。
  • 12个月神经性厌食、神经性贪食和暴食障碍患病率分别为0.05%(SE 0.02%)、0.14%(SE 0.02%)和0.44%(SE 0.04%)。
  • 调整年龄、种族和/或民族、教育、收入后,三种进食障碍终生和12个月诊断的 odds 女性均显著高于男性。
  • 终生神经性厌食诊断的 adjusted odds ratio 在非西班牙裔黑人和西班牙裔受访者中显著低于白人受访者。
  • 终生和12个月神经性贪食诊断的 adjusted odds ratio 按种族和/或民族无显著差异。

关键数值与推荐

  • 终生暴食障碍诊断的 adjusted odds ratio 在非西班牙裔黑人中显著低于非西班牙裔白人,但12个月诊断无显著差异。
  • 暴食障碍的 adjusted odds ratio 在西班牙裔和非西班牙裔白人之间无显著差异。
  • 神经性厌食、神经性贪食和暴食障碍在发病年龄、发作持续性和持续时间、当前肥胖率及心理社会损害率方面存在显著差异。

临床怎么用

  • 临床中应关注女性进食障碍的较高风险,并注意不同种族和民族在神经性厌食及暴食障碍诊断上的差异。
  • 评估进食障碍时需考虑发病年龄、病程持续性和心理社会损害等特征。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few population-based data on the prevalence of eating disorders exist, and such data are especially needed because of changes to diagnoses in the DSM-5. This study aimed to provide lifetime and 12-month prevalence estimates of DSM-5-defined anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED) from the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions. METHODS: A national sample of 36,306 U.S. adults completed structured diagnostic interviews (Alcohol Use Disorder and Associated Disabilities Interview Schedule-5). RESULTS: Prevalence estimates of lifetime AN, BN, and BED were 0.80% (SE 0.07%), 0.28% (SE 0.03%), and 0.85% (SE 0.05%), respectively. Twelve-month estimates for AN, BN, and BED were 0.05% (SE 0.02%), 0.14% (SE 0.02%), and 0.44% (SE 0.04%). The odds of lifetime and 12-month diagnoses of all three eating disorders were significantly greater for women than for men after adjusting for age, race and/or ethnicity, education, and income. Adjusted odds ratios (AORs) of lifetime AN diagnosis were significantly lower for non-Hispanic black and Hispanic respondents than for white respondents. AORs of lifetime and 12-month BN diagnoses did not differ significantly by race and/or ethnicity. The AOR of lifetime, but not 12-month, BED diagnosis was significantly lower for non-Hispanic black respondents relative to that of non-Hispanic white respondents; AORs of BED for Hispanic and non-Hispanic white respondents did not differ significantly. AN, BN, and BED were characterized by significant differences in age of onset, persistence and duration of episodes, and rates of current obesity and psychosocial impairment. CONCLUSIONS: These findings for DSM-5-defined eating disorders, based on the largest national sample of U.S. adults studied to date, indicate some important similarities to and differences from earlier, smaller nationally representative studies.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Udo T, Grilo CM. Prevalence and Correlates of DSM-5-Defined Eating Disorders in a Nationally Representative Sample of U.S. Adults. Biol Psychiatry. 2018. PMID: 29859631. doi:10.1016/j.biopsych.2018.03.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。